Nike Co-founder Phil Knight Commits $2 Billion to Cancer Initiative

Phil Knight, co-founder of Nike, is set to donate a remarkable $2 billion to the Cancer Institute at Oregon Health and Science University.

Transformational Gift

As per the announcement from the Knight Foundation, this unprecedented generosity is anticipated to fundamentally shift the paradigms of cancer research, enhance treatment methodologies, and improve patient outcomes.

Partnership with Pioneers

The donation is set to strengthen collaboration with renowned cancer researcher Dr. Brian Druker. Ten years ago, Druker and OHSU embarked on a bold initiative to amass $500 million for cancer research, with the Knights pledging to match the funds raised.

Statement from the Knights

Phil and Penny Knight expressed their enthusiasm for supporting the next phase of Druker's groundbreaking vision, stating they are thrilled about the transformative potential for humanity that this work promises.

Knight's Legacy

Phil Knight's wealth originates from his success with Nike, once a small company where he sold sneakers from his car trunk. Known initially as Blue Ribbon Sports, Nike became publicly traded in 1980 and has since dominated the athletic footwear market.

From its initial public offering to Knight's retirement in 2016, Nike's stock value increased phenomenally. Despite recent market challenges, Nike continues to be an industry leader with a valuation exceeding $110 billion.

Philanthropic Milestones

The Knights are recognized among the leading philanthropists. Their cumulative donations are estimated at $3.6 billion, including $370 million given in 2024 alone. The Knight Foundation reportedly managed assets worth over $5 billion by the end of 2023.

Phil Knight has expressed that creating something distinctly his own was his vision for a meaningful life. This sentiment reflects the deep personal commitment behind his philanthropic efforts.